Here are the DEF 14A proxy statements from Harvard Apprats REG TCH (HRGN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow HRGN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HRGN filings page.
Harvard Apparatus Regenerative Technology, Inc. is asking stockholders to vote at its 2026 Annual Meeting on three key items: electing three Class I directors, ratifying CBIZ CPAs P.C. as auditor for 2026, and approving a non-binding advisory vote on named executive officer pay.
The meeting will be held in person on June 18, 2026 at 9:30 a.m. Eastern Time at the company’s Holliston, Massachusetts headquarters. Stockholders of record as of April 21, 2026, when 17,580,744 common shares were outstanding, are entitled to vote one share per share held. The board states that all directors except the CEO are independent and recommends voting “FOR” all three proposals.
The proxy details board and committee structure, director biographies, executive employment terms, and 2025 compensation. CEO Junli (Jerry) He received total 2025 compensation of $439,969, while other named executives received between about $188,000 and $228,000. The filing also describes equity incentive plans, ownership of major shareholders and insiders, related-party bridge loans from the CEO, and the transition of audit work from Marcum LLP to CBIZ CPAs P.C.